Will ductal carcinoma in situ defeat breast cancer screening?

BMJ (Online)

Volumn 338, Issue 7695, 2009, Pages

  Benson, John R ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOPSY; BREAST BIOPSY; BREAST CARCINOMA; CANCER GRADING; CANCER GROWTH; CANCER SCREENING; CARCINOMA IN SITU; CLINICAL FEATURE; ECHOMAMMOGRAPHY; HEALTH PROGRAM; HUMAN; INFORMED CONSENT; INTRADUCTAL CARCINOMA; LETTER; MASTECTOMY; MEDICAL ERROR; MEDICAL INFORMATION; MORBIDITY; PRIORITY JOURNAL; PROGNOSIS; SOCIAL PSYCHOLOGY;

BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; MASS SCREENING;

EID: 84859007362     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b957     Document Type: Letter

References (5)

1. Gøtzsche PC, Hartling OJ, Nielsen M, Brodersen J, Jørgensen KJ. Breast screening: the facts-or maybe not. BMJ 2009;338:b86. (27 January.)[Free Full Text]
2. Surveillance, Epidemiology and End Results (SEER) Program. Cancer statistics review (1973-1995). Bethesda, MD: National Cancer Institute, 1998.
3. Andersen J, Neilsen M, Christensen L. New aspects of the natural history of in situ and invasive carcinoma in the female breast: results from autopsy investigations. Verh Dtsch Ges Pathol 1985;69:88-95.[Medline]
4. Welch HG, Black WC. Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of the breast: How much more breast cancer can we find? Ann Intern Med 1997;127:1023-8.[Abstract/Free Full Text]
5. Anderson TJ. Genesis and source of breast cancer. Br Med Bull 1991 ;47:305-18.[Abstract/Free Full Text]